TABLE 2.
Gene | Fold changea
|
|
---|---|---|
BM | Spleen | |
Ras-associated genes | ||
Ki-Ras | −1.5 ± 0.1 | 2.7 ± 0.2 |
PAC-1 ERK/MAPK phosphataseb | −2.3 ± 0.1 | −2.2 ± 0.2 |
Kinase suppressor of Ras (KSR1)b | 2.5 ± 0.3 | −2.5 ± 0.2 |
Rho A GTPase | −2.8 ± 0.3 | −1.1 ± 0.2 |
Rho B GTPase | −2.4 ± 0.3 | 2.4 ± 0.2 |
Raf | −5.2 ± 0.5 | −1.0 ± 0.3 |
GBP-2 GTPase | −3.3 ± 0.3 | 3.4 ± 0.2 |
SOS-2 | −2.7 ± 0.3 | 1.3 ± 0.2 |
Vav | −2.8 ± 0.3 | 1.7 ± 0.2 |
DAB-2 | −3.2 ± 0.3 | 1.0 ± 0.2 |
ERK-1 | −2.2 ± 0.2 | −1.2 ± 0.2 |
ERK-5 | −5.6 ± 0.3 | 1.7 ± 0.5 |
MEK-5 | −3.3 ± 0.2 | −1.3 ± 0.1 |
Notch-associated genes | ||
Delta (Dlk1-like) | 2.7 ± 0.2 | −2.3 ± 0.2 |
Enhancer of Split (mESG) | 2.2 ± 1.0 | −1.2 ± 0.2 |
Suppressor of Hairless (RBP-L) | 1.4 ± 0.2 | 2.3 ± 0.3 |
Sel 11 inhibitor of Notchb | −3.0 ± 0.2 | 4.2 ± 0.1 |
Identical microarray experiments were performed in duplicate with CD19+ bone marrow (BM) and splenic B cells from wild-type and LMP2A transgenic mice. The average fold change in gene expression in cells from LMP2A transgenic mice versus wild-type mice from the two experiments is shown, along with the standard deviation. Negative values indicate decreased expression.
Shown to be a positive or negative regulator, depending on the model system.